Sharon Mates, Chairman, President & CEO: Intra-Cellular Therapies ITCI Sell · Filed 23/09/19

Trade details

Type: Insider sale
Amount: $2,405,852.21
Shares · price: 44,413 sh · $54.17 a share
Held after: 1,050,309 sh
Stock: Intra-Cellular Therapies ITCI
Person: Sharon MatesChairman, President & CEO
Trade date: 23/09/19
Filed: 23/09/19
Days to filing: 0 days

Sold 4.1% of holdings

Share of holding sold: 4.1%

Intra-Cellular Therapies trades, last 26 weeks

What else happened in Intra-Cellular Therapies around then

Filed or reported within 30 days of the trade day · 23/08/20~23/10/19

Sharon Mates's recent trades

Sharon MatesChairman and CEO
Sell10b5-1 planIntra-Cellular Therapies
Sell10b5-1 plan
Intra-Cellular Therapies
ITCI
$4.2M
50,163 sh
$4.2M
Filed 24/12/06
Traded 24/12/05
Sharon MatesChairman and CEO
Sell10b5-1 planIntra-Cellular Therapies
Sell10b5-1 plan
Intra-Cellular Therapies
ITCI
$2.4M
27,667 sh
$2.4M
Filed 24/12/06
Traded 24/12/04
Sharon MatesChairman and CEO
Sell10b5-1 planIntra-Cellular Therapies
Sell10b5-1 plan
Intra-Cellular Therapies
ITCI
$2M
23,333 sh
$2M
Filed 24/12/06
Traded 24/12/04
Sharon MatesChairman and CEO
Sell10b5-1 planIntra-Cellular Therapies
Sell10b5-1 plan
Intra-Cellular Therapies
ITCI
$129.9K
1,534 sh
$129.9K
Filed 24/12/06
Traded 24/12/05
Sharon MatesChairman and CEO
Sell10b5-1 planIntra-Cellular Therapies
Sell10b5-1 plan
Intra-Cellular Therapies
ITCI
$2.2M
29,832 sh
$2.2M
Filed 24/08/30
Traded 24/08/29

Sharon Mates, Chairman — sold $2.4M of Intra-Cellular Therapies ITCI · 4.1% of holdings · 10b5-1 plan | Whalegun